Endovascular therapy for acute stroke: Quo vadis?

Abstract

Endovascular therapy (EVT) has gained vogue in the management of patients with acute stroke. Newer stent-retriever devices have led to better recanalization rates. In many centers, EVT is slowly being used as an add on to or in some instances, even as an alternative to intravenous tissue plasminogen activator (IV tPA). The publication of the results of the SYNTHESIS expansion, Interventional Management of Stroke III and Mechanical Retrieval Recanalization of Stroke Clots Using Embolectomy trials in 2013 has questioned the enthusiastic use of EVT in acute stroke. They demonstrate that EVT (using a variety of devices) is no superior to IV tPA in the management of acute stroke. In the light of these controversial findings, we review the current status of EVT in the management of acute stroke.

Key words

Acute stroke - clot retrieval - endovascular therapy - intravenous alteplase - stent-retrievers

• References

• 1 Dalal PM, Malik S, Bhattacharjee M, Trivedi ND, Vairale J, Bhat P. et al Population-based stroke survey in Mumbai, India: Incidence and 28-day case fatality. Neuroepidemiology 2008; 31: 254-261
• 2 Dalal PM, Bhattacharjee M. Stroke epidemic in India: Hypertension-stroke control programme is urgently needed. J Assoc Physicians India 2007; 55: 689-691
• 3 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
• 4 Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP. et al Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774
• 5 Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D. et al Thrombolysis with alteplase 3 to 4 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
• 6 Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD. et al Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-890
• 7 Mokin M, Kass-Hout T, Kass-Hout O, Dumont TM, Kan P, Snyder KV. et al Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: A systematic review of clinical outcomes. Stroke 2012; 43: 2362-2368
• 8 Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C. et al Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011
• 9 Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S. et al Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633-2639
• 10 Kass-Hout T, Kass-Hout O, Mokin M, Thesier DM, Yashar P, Orion D. et al Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?. World Neurosurg 2014; Sep-Oct 82 (3-4) e453 doi: 10.1016/j.wneu.2013.01.097
• 11 Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R. et al Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
• 12 Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. et al Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009; 73: 1066-1072
• 13 Ciccone A, Valvassori L, Ponzio M, Ballabio E, Gasparotti R, Sessa M. et al Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg 2010; 2: 74-79
• 14 Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Liang S. et al Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol 2013; 70: 353-358
• 15 Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG. et al Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
• 16 Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA. et al Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet 2012; 380: 1231-1240
• 17 Albuquerque FC. Bridging treatment and stroke. World Neurosurg 2014; 82 (3-4) e413-e414 doi: 10.1016/j.wneu.2013.02.086.
• 18 Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S. et al Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948-954
• 19 Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG. et al MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): A prospective cohort study. Lancet Neurol 2012; 11: 860-867
• 20 Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z. et al A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
• 21 Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP. et al Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005; 36: 1432-1438
• 22 Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC. et al Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): A prospective cohort study. Lancet Neurol 2009; 8: 802-809